Teva Pharma Industries Ltd ADR
Price & Volume
Stats
See moreOpen | $24.93 |
Previous Close | $24.77 |
Day Range | $24.79-$25.17 |
52W Range | $12.47-$26.38 |
Market Cap | $27.7B |
Shares Short | 50M |
Financials
See moreRevenue (12 Mos) | $16.7B |
Revenue Growth (YoY) | 3.4% |
Gross Profit (12 Mos) | $8.4B |
Diluted EPS | $0.61 |
News
See moreYahoo Finance • 10 hours ago
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
Yahoo Finance • 11 hours ago
Why Analysts See Teva’s Story Shifting With New Approvals and Rising Price Targets
Yahoo Finance • yesterday
This Investor Beat the Market for 3 Decades Without a Single Losing Year. 3 Stocks He’s Buying Now.
About
CEO | Mr. Richard D. Francis |
CFO | Mr. Eliyahu Sharon Kalif |
Address | 124 Dvora HaNevi?a St., Tel Aviv-Yafo, Israel, 6944020 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 33,892 |
